126 related articles for article (PubMed ID: 36395451)
21. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
[TBL] [Abstract][Full Text] [Related]
22. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
23. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
Murshed KA; Abo Samra H; Ammar A
Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
[TBL] [Abstract][Full Text] [Related]
24. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
25. D2-40 highlights lymphatic vessel proliferation of angiolymphoid hyperplasia with eosinophilia.
Miteva M; Galimberti ML; Ricotti C; Breza T; Kirsner R; Romanelli P
J Cutan Pathol; 2009 Dec; 36(12):1316-22. PubMed ID: 19602066
[TBL] [Abstract][Full Text] [Related]
26. Papular angiolymphoid hyperplasia and lymphoplasmacytic plaque: a clinical and histological spectrum.
Yeo YW; Oon HH; Lee JS; Pan JY; Mok YJ; Ng SK
Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617464
[TBL] [Abstract][Full Text] [Related]
27. Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy.
Zagars GK; Goswitz MS; Pollack A
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):311-9. PubMed ID: 8892453
[TBL] [Abstract][Full Text] [Related]
28. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
[TBL] [Abstract][Full Text] [Related]
30. Angiosarcomas of the skin.
Cooper PH
Semin Diagn Pathol; 1987 Feb; 4(1):2-17. PubMed ID: 3313596
[TBL] [Abstract][Full Text] [Related]
31. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
Tajima S; Koda K
Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
[TBL] [Abstract][Full Text] [Related]
32. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
33. Recurrent Pleomorphic Myxoid Liposarcoma in a Patient With Li-Fraumeni Syndrome.
Zare SY; Leivo M; Fadare O
Int J Surg Pathol; 2020 Apr; 28(2):225-228. PubMed ID: 31559875
[TBL] [Abstract][Full Text] [Related]
34. Myxoid liposarcoma with transition to round-cell lesion-cell cycle regulator genes and telomerase activity characterizing tumor progression: a case report.
Jaeger V; Schneider-Stock R; Gerresheim F; Epplen JT; Serra M; Lippert H; Roessner A
Hum Pathol; 1999 Dec; 30(12):1515-9. PubMed ID: 10667432
[TBL] [Abstract][Full Text] [Related]
35. Pseudolymphomatous Cutaneous Angiosarcoma Presenting With Persistent Firm Facial Edema in a Patient With Systemic Sclerosis.
Méndez-Flores S; Saeb-Lima M; Fragoso-Loyo HE
Am J Dermatopathol; 2024 Jun; ():. PubMed ID: 38842357
[TBL] [Abstract][Full Text] [Related]
36. Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features.
Ronchi A; Cozzolino I; Zito Marino F; De Chiara A; Argenziano G; Moscarella E; Pagliuca F; Franco R
Ann Diagn Pathol; 2020 Oct; 48():151597. PubMed ID: 32829071
[TBL] [Abstract][Full Text] [Related]
37. Liposarcoma: new entities and evolving concepts.
Dei Tos AP
Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
[TBL] [Abstract][Full Text] [Related]
38. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
39. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous angiosarcoma masquerading as herpes zoster.
Kast DR; Sammons D; Nixon RM; Geiss DF
Cutis; 2012 Jul; 90(1):42-5. PubMed ID: 22908732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
